142 related articles for article (PubMed ID: 17981296)
1. Expression of tight junction protein claudin-5 in tumor vessels and sinusoidal endothelium in patients with hepatocellular carcinoma.
Sakaguchi T; Suzuki S; Higashi H; Inaba K; Nakamura S; Baba S; Kato T; Konno H
J Surg Res; 2008 Jun; 147(1):123-31. PubMed ID: 17981296
[TBL] [Abstract][Full Text] [Related]
2. Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma.
Higashi Y; Suzuki S; Sakaguchi T; Nakamura T; Baba S; Reinecker HC; Nakamura S; Konno H
J Surg Res; 2007 May; 139(1):68-76. PubMed ID: 17270214
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance.
Tanigawa N; Lu C; Mitsui T; Miura S
Hepatology; 1997 Nov; 26(5):1216-23. PubMed ID: 9362365
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
Hira E; Ono T; Dhar DK; El-Assal ON; Hishikawa Y; Yamanoi A; Nagasue N
Cancer; 2005 Feb; 103(3):588-98. PubMed ID: 15612021
[TBL] [Abstract][Full Text] [Related]
5. High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases.
Ohmori S; Shiraki K; Sugimoto K; Sakai T; Fujikawa K; Wagayama H; Takase K; Nakano T
Hum Pathol; 2001 Dec; 32(12):1363-70. PubMed ID: 11774170
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of E-cadherin, CD34 in the patients with hepatocellular carcinoma].
Wu LQ; Lu Y; Lu HJ; Zhang B; Yang JY; Ma X
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):774-7. PubMed ID: 16836930
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
Fang F; Luo LB; Tao YM; Wu F; Yang LY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma.
Nakamura S; Muro H; Suzuki S; Sakaguchi T; Konno H; Baba S; Syed AS
Hepatology; 1997 Aug; 26(2):407-15. PubMed ID: 9252152
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.
Ruck P; Xiao JC; Kaiserling E
Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428
[TBL] [Abstract][Full Text] [Related]
11. Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma.
Sakamoto M; Ino Y; Fujii T; Hirohashi S
Jpn J Clin Oncol; 1993 Apr; 23(2):98-104. PubMed ID: 7685837
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
[TBL] [Abstract][Full Text] [Related]
13. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
14. [Clinical values of vascular endothelial growth factor expression and microvascular density analysis in liver cancer specimens].
Yao DF; Zhu Y; Wu XH; Wu W; Qiu LW
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):92-4. PubMed ID: 14980110
[TBL] [Abstract][Full Text] [Related]
15. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
[TBL] [Abstract][Full Text] [Related]
16. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
[TBL] [Abstract][Full Text] [Related]
17. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
18. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of artery in moderately differentiated hepatocellular carcinoma related to tumor development.
Fujita N; Aishima S; Iguchi T; Nishihara Y; Yamamoto H; Taketomi A; Oda Y; Honda H; Tsuneyoshi M
Hum Pathol; 2010 Jun; 41(6):838-47. PubMed ID: 20185161
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between blood flow velocity of feeding arteries and microvessel density of hepatocellular carcinoma].
Dong L; Zhang CS; Guan YF; Zhang Y; Zhao XF
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):538-40. PubMed ID: 16438851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]